nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical Trial Patient-reported Outcomes Data: Going Beyond the Label in Oncology
|
Hao, Yanni |
|
2016 |
38 |
4 |
p. 811-820 10 p. |
artikel |
2 |
Comments on Watson, the Microbiome of Children, and Patient-reported Outcomes
|
Shader, Richard I. |
|
2016 |
38 |
4 |
p. 683-685 3 p. |
artikel |
3 |
Cost-effectiveness of First-line Chronic Lymphocytic Leukemia Treatments When Full-dose Fludarabine Is Unsuitable
|
Soini, Erkki |
|
2016 |
38 |
4 |
p. 889-904.e14 9.03999999999991E16 p. |
artikel |
4 |
Development of the Neonatal Intestinal Microbiome and Its Association With Necrotizing Enterocolitis
|
Elgin, Timothy G. |
|
2016 |
38 |
4 |
p. 706-715 10 p. |
artikel |
5 |
Drug Therapy for Rate and Rhythm Control in Nonvalvular Atrial Fibrillation: A Cross-sectional Study With Electronic Health Records in a Primary Care Cohort
|
Giner-Soriano, Maria |
|
2016 |
38 |
4 |
p. 863-873 11 p. |
artikel |
6 |
Dual Antiplatelet Therapy Duration: A Review of Current Available Evidence
|
Mastoris, Ioannis |
|
2016 |
38 |
4 |
p. 961-973 13 p. |
artikel |
7 |
Editorial Board
|
|
|
2016 |
38 |
4 |
p. A2- 1 p. |
artikel |
8 |
Effectiveness of Everolimus Versus Endocrine Monotherapy or Chemotherapy Among HR+/HER2− mBC Patients With Multiple Metastatic Sites
|
Li, Nanxin |
|
2016 |
38 |
4 |
p. 905-917 13 p. |
artikel |
9 |
Effects of Modafinil and Armodafinil in Patients With Obstructive Sleep Apnea: A Meta-analysis of Randomized Controlled Trials
|
Kuan, Yi-Chun |
|
2016 |
38 |
4 |
p. 874-888 15 p. |
artikel |
10 |
Efficacy and Safety of the SGLT2 Inhibitor Luseogliflozin in Japanese Patients With Type 2 Diabetes Mellitus Stratified According to Baseline Body Mass Index: Pooled Analysis of Data From 52-Week Phase III Trials
|
Sakai, Soichi |
|
2016 |
38 |
4 |
p. 843-862.e9 8.61999999158E11 p. |
artikel |
11 |
From Bottles to Diapers: How Manipulating and Exploring the Microbiome Is Defining Newborn Care
|
Maron, Jill L. |
|
2016 |
38 |
4 |
p. 704-705 2 p. |
artikel |
12 |
IBM Watson: How Cognitive Computing Can Be Applied to Big Data Challenges in Life Sciences Research
|
Chen, Ying |
|
2016 |
38 |
4 |
p. 688-701 14 p. |
artikel |
13 |
Increasing Incidence of Thyroid Nodules and Thyroid Cancer: Does Increased Detection of a Subclinical Reservoir Justify the Associated Anxiety and Treatment?
|
Ukrainski, Melinda B. |
|
2016 |
38 |
4 |
p. 976-985 10 p. |
artikel |
14 |
Methods for Implementing and Reporting Patient-reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical Trials
|
Basch, Ethan |
|
2016 |
38 |
4 |
p. 821-830 10 p. |
artikel |
15 |
Neonatal Gastrointestinal and Respiratory Microbiome in Cystic Fibrosis: Potential Interactions and Implications for Systemic Health
|
Madan, Juliette C. |
|
2016 |
38 |
4 |
p. 740-746 7 p. |
artikel |
16 |
New Formulations of Old Analgesics and Repurposing of Old Drugs as “New” Analgesics
|
Ruan, Xiulu |
|
2016 |
38 |
4 |
p. 988-989 2 p. |
artikel |
17 |
Opportunity Cost and Policy: A Utilization Review of Self-monitoring of Blood Glucose in Manitoba, Canada
|
Serwylo, Olena |
|
2016 |
38 |
4 |
p. 929-935 7 p. |
artikel |
18 |
Patient-reported Symptom Experiences in Patients With Carcinoid Syndrome After Participation in a Study of Telotristat Etiprate: A Qualitative Interview Approach
|
Gelhorn, Heather L. |
|
2016 |
38 |
4 |
p. 759-768 10 p. |
artikel |
19 |
Patient-reported Symptoms of Tenosynovial Giant Cell Tumors
|
Gelhorn, Heather L. |
|
2016 |
38 |
4 |
p. 778-793 16 p. |
artikel |
20 |
Pharmacokinetics, Efficacy, and Safety of Nonacog Alfa in Previously Treated Patients with Moderately Severe to Severe Hemophilia B
|
Korth-Bradley, Joan M. |
|
2016 |
38 |
4 |
p. 936-944 9 p. |
artikel |
21 |
Prevention of Necrotizing Enterocolitis Through Manipulation of the Intestinal Microbiota of the Premature Infant
|
Vongbhavit, Kannikar |
|
2016 |
38 |
4 |
p. 716-732 17 p. |
artikel |
22 |
Qualitative Development and Content Validity of the Non–small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument
|
McCarrier, Kelly P. |
|
2016 |
38 |
4 |
p. 794-810 17 p. |
artikel |
23 |
Reducing Adverse Effects During Drug Development: The Example of Lesogaberan and Paresthesia
|
Rydholm, Hans |
|
2016 |
38 |
4 |
p. 946-960 15 p. |
artikel |
24 |
Safety of the Up-titration of Nifedipine GITS and Valsartan or Low-dose Combination in Uncontrolled Hypertension: the FOCUS Study
|
Park, Jeong Bae |
|
2016 |
38 |
4 |
p. 832-842 11 p. |
artikel |
25 |
Table of Contents
|
|
|
2016 |
38 |
4 |
p. A4-A6 nvt p. |
artikel |
26 |
The Developing Microbiome of the Preterm Infant
|
DiBartolomeo, Mara E. |
|
2016 |
38 |
4 |
p. 733-739 7 p. |
artikel |
27 |
The Hypoxia-inducible Factor Prolyl-Hydroxylase Inhibitor Roxadustat (FG-4592) and Warfarin in Healthy Volunteers: A Pharmacokinetic and Pharmacodynamic Drug–Drug Interaction Study
|
Groenendaal-van de Meent, Dorien |
|
2016 |
38 |
4 |
p. 918-928 11 p. |
artikel |
28 |
The Microbiome in Necrotizing Enterocolitis: A Case Report in Twins and Minireview
|
Hourigan, Suchitra K. |
|
2016 |
38 |
4 |
p. 747-753 7 p. |
artikel |
29 |
The Use of Patient-reported Outcomes in Demonstrating Safety and Efficacy in Oncology
|
Coon, Cheryl D. |
|
2016 |
38 |
4 |
p. 756-758 3 p. |
artikel |
30 |
Using Patient-reported Outcomes to Compare Relative Burden of Cancer: EQ-5D and Functional Assessment of Cancer Therapy-General in Eleven Types of Cancer
|
Pickard, A. Simon |
|
2016 |
38 |
4 |
p. 769-777 9 p. |
artikel |